Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
These medications carry a boxed warning about thyroid C-cell tumors observed in rodent studies and are contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
By targeting metabolic pathways, the peptide may reduce liver fat accumulation and improve liver function, addressing a condition that often accompanies obesity and diabetes
In clinical trials, patients observed a rapid onset of satiety that helped them eat smaller portions at each meal
If approved, the drug can be commercially manufactured and prescribed to patients
US$ 22.40
US$ 20.35
US$ 20.96
US$ 22.99
US$ 29.80
US$ 26.56
US$ 20.20
US$ 27.17
US$ 21.69
US$ 28.62
